Amaryl and Type 1 diabetes - a phase IV clinical study of FDA data

Summary:

Type 1 diabetes is reported as a side effect among people who take Amaryl (glimepiride), especially for people who are male, 60+ old, have been taking the drug for 5 - 10 years also take Seroquel, and have Depression.

The phase IV clinical study analyzes which people have Type 1 diabetes when taking Amaryl. It is created by eHealthMe based on reports of 31,980 people who have side effects when taking Amaryl from the FDA, and is updated regularly.

What is Amaryl?

Amaryl has active ingredients of glimepiride. It is often used in diabetes. eHealthMe is studying from 32,259 Amaryl users. Check the latest studies of Amaryl.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

31,980 people reported to have side effects when taking Amaryl.
Among them, 50 people (0.16%) have Type 1 diabetes.

Among these 50 people:

How long have people been on Amaryl when they have Type 1 diabetes? *

What is the gender of people who have Type 1 diabetes when taking Amaryl? *

female: 48.98 %
male: 51.02 %

What is the age of people who have Type 1 diabetes when taking Amaryl? *

What are other drugs people take besides Amaryl? *

What are other side effects people have besides Type 1 diabetes? *

High Blood Pressure: 13 people, 26.00%
Pain: 12 people, 24.00%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 11 people, 22.00%
Nausea (feeling of having an urge to vomit): 8 people, 16.00%
Joint Pain: 8 people, 16.00%
Pneumonia: 8 people, 16.00%
Oedema Peripheral (superficial swelling): 8 people, 16.00%
Pain In Extremity: 8 people, 16.00%
Hyperlipidaemia (presence of excess lipids in the blood): 8 people, 16.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 14.00%

What are the existing conditions these people have? *

Depression: 11 people, 22.00%
Stress And Anxiety: 9 people, 18.00%
Bipolar Disorder (mood disorder): 7 people, 14.00%
Insomnia (sleeplessness): 6 people, 12.00%
Sleep Disorder: 5 people, 10.00%
High Blood Pressure: 5 people, 10.00%
Psychotic Disorder: 4 people, 8.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 8.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 8.00%
Pancreatitis Chronic (chronic inflammation of pancreas): 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Amaryl and have Type 1 diabetes?

- Check whether Type 1 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amaryl:

Amaryl (32,259 reports)

Type 1 diabetes treatments and more:

Type 1 diabetes (46,846 reports)

Browse all side effects of Amaryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 1 diabetes:

Type 1 diabetes (668 drugs)

Browse all the conditions that are associated with Type 1 diabetes:

Type 1 diabetes (1,644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glimepiride (the active ingredients of Amaryl) and Amaryl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.